Medtronic plc (BVMF:MDTC34)
Brazil · Delayed Price · Currency is BRL 273.36
+3.06 (1.13%)
At close: Feb 5, 2026
Revenue
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 24, 2025 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 23, 2013 |
Cardiac Rhythm & Heart Failure Revenue | 6.82B | 6.39B | 6.00B | |||||||||||
Cardiac Rhythm & Heart Failure Revenue Growth | 6.62% | 6.62% | 3.67% | |||||||||||
Structural Heart & Aortic Revenue | 3.70B | 3.55B | 3.36B | |||||||||||
Structural Heart & Aortic Revenue Growth | 4.22% | 5.84% | -0.15% | |||||||||||
Coronary & Peripheral Vascular Revenue | 2.58B | 2.54B | 2.48B | |||||||||||
Coronary & Peripheral Vascular Revenue Growth | 1.58% | 2.30% | 4.34% | |||||||||||
Cardiovascular Revenue | 13.09B | 12.48B | 11.83B | |||||||||||
Cardiovascular Revenue Growth | 4.91% | 5.49% | 2.68% | |||||||||||
Cranial & Spinal Technologies Revenue | 5.10B | 4.97B | 4.76B | |||||||||||
Cranial & Spinal Technologies Revenue Growth | 2.59% | 4.56% | 6.85% | |||||||||||
Specialty Therapies Revenue | 2.94B | 2.94B | 2.91B | |||||||||||
Specialty Therapies Revenue Growth | -0.10% | 1.21% | 3.20% | |||||||||||
Neuromodulation Revenue | 2.02B | 1.93B | 1.75B | |||||||||||
Neuromodulation Revenue Growth | 4.55% | 10.65% | 3.13% | |||||||||||
Neuroscience Revenue | 10.06B | 9.85B | 9.41B | |||||||||||
Neuroscience Revenue Growth | 2.13% | 4.68% | 4.99% | |||||||||||
Surgical & Endoscopy Revenue | 6.60B | 6.50B | 6.51B | |||||||||||
Surgical & Endoscopy Revenue Growth | 1.51% | -0.15% | 5.79% | |||||||||||
Acute Care & Monitoring Revenue | 1.94B | 1.91B | 1.91B | |||||||||||
Acute Care & Monitoring Revenue Growth | 1.78% | 0.05% | 3.86% | |||||||||||
Medical Surgical Revenue | 8.54B | 8.41B | 8.42B | |||||||||||
Medical Surgical Revenue Growth | 1.56% | -0.12% | 5.36% | |||||||||||
Diabetes Revenue | 2.90B | 2.76B | 2.49B | |||||||||||
Diabetes Revenue Growth | 5.26% | 10.73% | 9.99% | |||||||||||
Other Segment Revenue | 170.00M | 137.00M | 221.00M | |||||||||||
Other Segment Revenue Growth | 24.09% | -38.01% | -55.35% | |||||||||||
Revenue (Other) | - | -89.00M | 1.00M | |||||||||||
Revenue (Total) | 34.76B | 33.54B | 32.36B | |||||||||||
Revenue (Total) Growth | 3.64% | 3.62% | 3.64% |
Revenue by Geography
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 24, 2025 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 23, 2013 |
U.S. Revenue | 17.52B | 17.17B | 16.56B | |||||||||||
U.S. Revenue Growth | 2.06% | 3.68% | 1.15% | |||||||||||
Non-U.S. Developed Markets Revenue | - | 10.20B | 9.98B | |||||||||||
Non-U.S. Developed Markets Revenue Growth | - | 2.21% | 6.07% | |||||||||||
Emerging Markets Revenue | - | 6.20B | 5.82B | |||||||||||
Emerging Markets Revenue Growth | - | 6.47% | 6.92% | |||||||||||
Total International Revenue | 17.23B | 16.37B | 15.80B | |||||||||||
Total International Revenue Growth | 5.31% | 3.56% | 6.38% | |||||||||||
Revenue (Other) | - | 1.00M | - | |||||||||||
Revenue (Total) | 34.76B | 33.54B | 32.36B | |||||||||||
Revenue (Total) Growth | 3.64% | 3.62% | 3.64% |
EBIT
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 24, 2025 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 23, 2013 |
Cardiovascular Operating Profit | 4.22B | 4.80B | 4.47B | |||||||||||
Cardiovascular Operating Profit Growth | -12.16% | 7.31% | 0.49% | |||||||||||
Neuroscience Operating Profit | 3.64B | 4.18B | 3.94B | |||||||||||
Neuroscience Operating Profit Growth | -12.91% | 6.17% | 6.14% | |||||||||||
Medical Surgical Operating Profit | 2.60B | 3.04B | 3.17B | |||||||||||
Medical Surgical Operating Profit Growth | -14.43% | -4.04% | 4.00% | |||||||||||
Diabetes Operating Profit | 352.00M | 491.00M | 394.00M | |||||||||||
Diabetes Operating Profit Growth | -28.31% | 24.62% | 2.87% | |||||||||||
Operating Income (Other) | -4.60B | -6.56B | -6.83B | |||||||||||
Operating Income (Total) | 6.21B | 5.96B | 5.14B | |||||||||||
Operating Income (Total) Growth | 4.33% | 15.77% | -6.22% |
Key Performance Indicators
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 23, 2013 |
Cardiovascular Organic Revenue Growth | 6.30% | 5.00% | |||||||||||
Neuroscience Organic Revenue Growth | 5.20% | 5.20% | |||||||||||
Medical Surgical Organic Revenue Growth | 0.80% | 4.70% | |||||||||||
Diabetes Organic Revenue Growth | 11.50% | 8.60% | |||||||||||
Total Organic Revenue Growth | 4.90% | 5.20% |
Updated Oct 24, 2025. Data Source: Fiscal.ai.